NASDAQ:RGEN
Repligen Corporation Stock News
$167.05
+0.740 (+0.445%)
At Close: May 03, 2024
LGND vs. RGEN: Which Stock Is the Better Value Option?
12:48pm, Friday, 21'st Oct 2022
LGND vs. RGEN: Which Stock Is the Better Value Option?
Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From Yesterday
05:52am, Thursday, 20'th Oct 2022 Benzinga
Gainers
Amprius Technologies, Inc. (NYSE: AMPX) jumped 77.3% to settle at $11.01 on Wednesday after the company announced it was awarded a $50 million cost-sharing grant from the U.S. Department of E
Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday's Mid-Day Session
04:30pm, Wednesday, 19'th Oct 2022 Benzinga
Gainers
SenesTech, Inc. (NASDAQ: SNES) shares jumped 102.6% to $0.47 after declining over 3% on Tuesday. SenesTech, during August, posted a Q2 loss of $0.21 per share.
Scopus BioPharma Inc. (NASDAQ:
Abbott Laboratories, M&T Bank And Some Other Big Stocks Moving Lower On Wednesday
02:36pm, Wednesday, 19'th Oct 2022 Benzinga
U.S. stocks traded higher, with the Dow Jones gaining more than 100 points on Wednesday. Here are some big stocks recording losses in today’s session.
Olaplex Holdings, Inc. (NASDAQ: OLPX) shares
Repligen (RGEN) is a Top-Ranked Growth Stock: Should You Buy?
01:45pm, Monday, 17'th Oct 2022 Zacks Investment Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Repligen (RGEN) is a Top-Ranked Growth Stock: Should You Buy?
11:17am, Monday, 17'th Oct 2022
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Repligen to Report Third Quarter 2022 Financial Results
11:30am, Wednesday, 12'th Oct 2022 GlobeNewswire Inc.
Webcast and Conference Call to Be Held Tuesday, November 1, 2022 at 8:30 a.m. EDT Webcast and Conference Call to Be Held Tuesday, November 1, 2022 at 8:30 a.m. EDT
Repligen to Report Third Quarter 2022 Financial Results
07:30am, Wednesday, 12'th Oct 2022
Webcast and Conference Call to Be Held Tuesday, November 1, 2022 at 8:30 a.m. EDT Webcast and Conference Call to Be Held Tuesday, November 1, 2022 at 8:30 a.m. EDT
4 under-the-radar stock picks from a five-star fund manager who sees rewards that are worth the risks
01:26pm, Friday, 07'th Oct 2022 MarketWatch
Jonathan Good, manager of the Baird Small/Mid Cap Growth Fund, explains his index-beating strategy in an interview.
4 under-the-radar stock picks from a five-star fund manager who sees rewards that are worth the risks
03:04pm, Thursday, 06'th Oct 2022
It can be tempting to chase performance during any given year, but unfortunately it's a tried-and-true way to lower your investment returns in the long run.
REGN vs. RGEN: Which Stock Is the Better Value Option?
03:40pm, Tuesday, 04'th Oct 2022 Zacks Investment Research
REGN vs. RGEN: Which Stock Is the Better Value Option?
REGN vs. RGEN: Which Stock Is the Better Value Option?
12:47pm, Tuesday, 04'th Oct 2022
REGN vs. RGEN: Which Stock Is the Better Value Option?
Repligen: Now Best Biotech Nearby Cap-Gain Prospect
11:44am, Tuesday, 27'th Sep 2022
Biotech stocks' bad investment reputations often (not always) come from failed lab tests. But today's opportunity comes from overenergetic market correction. A week ago I highlighted BGNE as the most
Repligen Expands Process Analytics Portfolio with DRS Daylight Solutions Agreement
08:01pm, Monday, 19'th Sep 2022 GlobeNewswire Inc.
Signs 15-year Strategic Collaboration and Exclusive License Agreement Signs 15-year Strategic Collaboration and Exclusive License Agreement
Repligen (RGEN) is a Top-Ranked Growth Stock: Should You Buy?
01:45pm, Monday, 19'th Sep 2022 Zacks Investment Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
